Enact Reports First Quarter 2025 Results
Enact Reports First Quarter 2025 Results
GAAP Net Income of $166 million , or $1.08 per diluted share Adjusted Operating Income of $169 million , or $1.10 per diluted share
Retuon Equity of 13.1% and Adjusted Operating Retuon Equity of 13.4% Primary Insurance in-force of $268 billion , a 2% increase from first quarter 2024 PMIERs Sufficiency of 165% or approximately $2.0 billion
Book Value Per Share of $33.96 and Book Value Per Share excluding AOCI of $34.97
"We had a strong start to 2025 and continue to make progress against our priorities," stated
Key Financial Highlights
|
(In millions, except per share data or otherwise noted) |
1Q25 |
4Q24 |
1Q24 |
|
Net Income (loss) |
|
|
|
|
Diluted Net Income (loss) per share |
|
|
|
|
Adjusted Operating Income (loss) |
|
|
|
|
Adj. Diluted Operating Income (loss) per share |
|
|
|
|
NIW ($B) |
|
|
|
|
Primary Persistency Rate |
84% |
82% |
85% |
|
Primary IIF ($B) |
|
|
|
|
Net Premiums Earned |
|
|
|
|
Losses Incurred |
|
|
|
|
Loss Ratio |
12% |
10% |
8% |
|
Operating Expenses |
|
|
|
|
Expense Ratio |
21% |
24% |
22% |
|
Net Investment Income |
|
|
|
|
Net Investment gains (losses) |
|
|
|
|
Retuon Equity |
13.1% |
13.0% |
13.8% |
|
Adjusted Operating Retuon Equity |
13.4% |
13.5% |
14.2% |
|
PMIERs Sufficiency ($) |
|
|
|
|
PMIERs Sufficiency (%) |
165% |
167% |
163% |
First Quarter 2025 Financial and Operating Highlights
Net income was
New insurance written (NIW) was approximately
Persistency remained elevated at 84%, up from 82% in the fourth quarter of 2024 and down from 85% in the first quarter of 2024. Approximately 8% of the mortgages in our portfolio had rates at least 50 basis points above March 2025's average mortgage rate of 6.7%.
Primary insurance in-force (IIF) was
Net premiums earned were
adjacencies and growth in primary insurance in-force, partially offset by higher ceded premiums.
Losses incurred for the first quarter of 2025 were
Operating expenses in the current quarter were
Net investment income was
Net investment gains (losses) in the quarter were
Annualized retuon equity for the first quarter of 2025 was 13.1% and annualized adjusted operating retuon equity was 13.4%. This compares to fourth quarter 2024 results of 13.0% and 13.5%, respectively, and to first quarter 2024 results of 13.8% and 14.2%, respectively.
Capital and Liquidity
We announced two excess-of-loss reinsurance agreements with a panel of highly-rated reinsurers that will provide approximately
We paid approximately
PMIERs sufficiency was 165% and
Recent Events
We repurchased approximately 2.0 million shares at an average price of
We announced today that the Company's Board of Directors approved a new share repurchase program with authorization to purchase up to
Additionally, the Board of Directors declared a 14% increase to our quarterly dividend from
Conference Call and Financial Supplement Information
This press release, the first quarter 2025 financial supplement and earnings presentation are now posted on the Company's website,
https://ir.enactmi.com. Investors are encouraged to review these materials.
Enact will discuss first quarter financial results in a conference call tomorrow,
/events.
The webcast will also be archived on the Company's website for one year.
About Enact
Enact (Nasdaq: ACT), operating principally through its wholly-owned subsidiary
Safe Harbor Statement
This communication contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may address, among other things, our expected financial and operational results, the related assumptions underlying our expected results, guidance concerning the future retuof capital and the quotations of management. These forward-looking statements are distinguished by use of words such as "will," "may," "would," "anticipate," "expect," "believe," "designed," "plan," "predict," "project," "target," "could," "should," or "intend,"
the negative of these terms, and similar references to future periods. These views involve risks and uncertainties that are difficult to predict and, accordingly, our actual results may differ materially from the results discussed in our forward-looking statements. Our forward-looking statements contained herein speak only as of the date of this press release. Factors or events that we cannot predict, including risks related to an economic downtuor a recession in
Although Enact believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, Enact can give no assurance that its expectations will be achieved and it undertakes no obligation to update publicly any forward-looking statements as a result of new information, future events, or otherwise, except as required by applicable law.
GAAP/Non-GAAP Disclosure Discussion
This communication includes the non-GAAP financial measures entitled "adjusted operating income (loss)", "adjusted operating income (loss) per share," and "adjusted operating retuon equity."
While some of these items may be significant components of net income (loss) in accordance with
Adjustments to reconcile net income (loss) available to
The tables at the end of this press release provide a reconciliation of net income (loss) to adjusted operating income (loss) and
|
1Q25 |
4Q24 |
1Q24 |
|
|
REVENUES: |
|||
|
Premiums |
|
|
|
|
Net investment income |
63,037 |
62,624 |
57,111 |
|
Net investment gains (losses) |
(3,243) |
(7,167) |
(6,684) |
|
Other income |
2,196 |
584 |
402 |
|
Total revenues |
306,776 |
301,776 |
291,576 |
|
LOSSES AND EXPENSES: |
|||
|
Losses incurred |
30,541 |
23,813 |
19,501 |
|
Acquisition and operating expenses, net of deferrals |
50,094 |
55,325 |
50,934 |
|
Amortization of deferred acquisition costs and intangibles |
2,429 |
2,522 |
2,259 |
|
Interest expense |
12,291 |
12,262 |
12,961 |
|
Total losses and expenses |
95,355 |
93,922 |
85,655 |
|
INCOME BEFORE INCOME TAXES |
211,421 |
207,854 |
205,921 |
|
Provision for income taxes |
45,643 |
45,116 |
44,933 |
|
NET INCOME |
|
|
|
|
Net investment (gains) losses Costs associated with reorganization Taxes on adjustments Adjusted Operating Income Loss ratio (1) Expense ratio (2) Earnings Per Share Data: Net Income per share Basic Diluted Adj operating income per share Basic Diluted Weighted-average common shares outstanding Basic Diluted |
3,243 629 (813) |
7,167 411 (1,591) |
6,684 (42) (1,395) |
|
|
|
|
|
|
12% 21% 151,831 152,907 |
10% 24% 153,537 154,542 |
8% 22% 158,818 160,087 |
-
The ratio of losses incurred to net earned premiums.
-
The ratio of acquisition and operating expenses, net of deferrals, and amortization of deferred acquisition costs and intangibles to net earned premiums. Expenses associated with strategic transaction preparations and restructuring costs increased the expense ratio by zero percentage points for the three-month period ended
March 31, 2025 , one percentage point for the three-month period endedDecember 31, 2024 , and zero percentage points for the three-month period endedMarch 31, 2024 .
Exhibit B: Consolidated Balance Sheets (amounts in thousands, except per share amounts)
|
Assets |
1Q25 |
4Q24 |
1Q24 |
|
Investments: Fixed maturity securities available-for-sale, at fair value Short term investments |
3,696 |
3,367 |
9,963 |
|
Total investments |
5,819,033 |
5,628,140 |
5,361,101 |
|
Cash and cash equivalents |
635,269 |
599,432 |
614,330 |
|
Accrued investment income |
49,654 |
49,595 |
43,450 |
|
Deferred acquisition costs |
23,322 |
23,771 |
24,861 |
|
Premiums receivable |
46,451 |
53,031 |
43,927 |
|
Other assets |
103,351 |
102,549 |
126,644 |
|
Deferred tax asset |
44,440 |
65,013 |
89,370 |
|
Total assets |
|
|
|
|
Liabilities and Shareholders' Equity Liabilities: Loss reserves Unearned premiums Other liabilities Long-term borrowings |
208,667 743,399 |
142,990 743,050 |
173,500 746,090 |
|
Total liabilities |
1,602,113 |
1,525,435 |
1,589,919 |
|
Equity: Common stock Additional paid-in capital Accumulated other comprehensive income Retained earnings |
1,508 2,007,776 (152,482) 3,262,605 |
1,523 2,076,788 (207,455) 3,125,240 |
1,577 2,264,198 (237,477) 2,685,466 |
|
Total equity |
5,119,407 |
4,996,096 |
4,713,764 |
|
Total liabilities and equity |
|
|
|
|
Book value per share |
|
|
|
|
Book value per share excluding AOCI |
|
|
|
|
|
13.1% |
13.0% |
13.8% |
|
Net investment (gains) losses |
0.3% |
0.6% |
0.6% |
|
Costs associated with reorganization |
0.0% |
0.0% |
0.0% |
|
(Gains) losses on early extinguishment of debt |
0.0% |
0.0% |
0.0% |
|
Taxes on adjustments |
(0.1)% |
(0.1)% |
(0.1)% |
|
Adjusted Operating ROE(2) |
13.4% |
13.5% |
14.2% |
|
Debt to Capital Ratio |
13% |
13% |
14% |
-
Calculated as annualized net income for the period indicated divided by the average of current period and prior periods' ending total stockholders' equity
-
Calculated as annualized adjusted operating income for the period indicated divided by the average of current period and prior periods' ending total stockholders' equity
This press release was published by a CLEAR® Verified individual.
Investor Contact
Attachments
Disclaimer



AXIS Capital Q1 2025 Financial Supplement
First Quarter 2025 Company Fact Sheet
Advisor News
- Americans less confident about retirement as worries grow
- 6 in 10 Americans struggle with financial decisions
- Trump bets his tax cuts will please Las Vegas voters on his swing West
- Lifetime income is the missing link to global retirement security
- Don’t let caregiving derail your clients’ retirement
More Advisor NewsAnnuity News
- Allianz Life Adds New Accumulation-Focused Fixed Index Annuities
- Allianz Life adds new accumulation-focused FIAs
- Industry objects to ‘tone and tenor’ of draft NAIC Annuity Buyer’s Guide
- Annuity industry grapples with consolidation, innovation and planning shifts
- Human connection still key in the new annuity era
More Annuity NewsHealth/Employee Benefits News
- UnitedHealth stock jumps as profit and outlook signal start of turnaround
- UnitedHealth profit and outlook signal start of turnaround
- WellTheory Expands Partnership with SISC to Support Hundreds of Thousands of School Employees and Their Families with Autoimmune Care
- Virginia Dems spar with governor over money to pay looming bills
- WASHINGTON'S HEPATITIS C ELIMINATION INITIATIVE EXPANDED ACCESS TO TESTING AND TREATMENT WHILE REDUCING PER-PATIENT COSTS, UW-LED STUDY FINDS
More Health/Employee Benefits NewsLife Insurance News
- Life insurance for gig economy power earners: what advisors need to know
- Allianz Life Adds New Accumulation-Focused Fixed Index Annuities
- Milliman Launches Healthcare Inflation ETFs (MHIG & MHIP) to Hedge the Rising Cost of U.S. Healthcare
- National Life Group Releases its 2025 Annual Report and Business Highlights
- Is life insurance through an employer enough?
More Life Insurance News